{
  "$schema": "folio-library-document/v1",
  "id": "10665-59577",
  "title": "Guidelines for the prevention and control of infection with LAV/HTLV III",
  "variant": "pdf",
  "pages": 20,
  "tocSource": "none",
  "tocMethod": null,
  "toc": [],
  "sections": [
    {
      "id": "page-001",
      "number": null,
      "title": "Page 1",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 1,
      "labelStart": null,
      "labelEnd": null,
      "words": 50,
      "summary": {
        "text": "The cover page of WHO's May 1986 guidelines for the prevention and control of infection with LAV/HTLV-III (document WHO/CDS/AIDS/86.1), with handwritten annotations rendered as garbled OCR.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "hel",
          "heading": false
        },
        {
          "term": "eee",
          "heading": false
        },
        {
          "term": "rene",
          "heading": false
        }
      ],
      "extract": "‘, WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Aeguired rene ur he fr eee. AELV- i wHo /CDS/AIDS/86.14° ORIGINAL: ENGLISH An hel poe if ¢. ae al e _ f prbresh ten ated tou 2? bsg! GUIDELINES FOR THE PREVENTION AND CONTROL OF INFECTION WITH LAV/RTLV IIIT May 1986",
      "extractCut": false,
      "blocks": [
        "library/10665-59577/blocks/prose-page-001"
      ]
    },
    {
      "id": "page-002",
      "number": null,
      "title": "Page 2",
      "level": 1,
      "pageStart": 2,
      "pageEnd": 2,
      "labelStart": null,
      "labelEnd": null,
      "words": 5,
      "summary": {
        "text": "A blank page with no extracted text.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "_(no text on this page)_",
      "extractCut": false,
      "blocks": [
        "library/10665-59577/blocks/prose-page-002"
      ]
    },
    {
      "id": "page-003",
      "number": null,
      "title": "Page 3",
      "level": 1,
      "pageStart": 3,
      "pageEnd": 3,
      "labelStart": null,
      "labelEnd": null,
      "words": 227,
      "summary": {
        "text": "The introductory page and first part of the contents of the 1986 LAV/HTLV-III guidelines, explaining that they are broad, based on Member State experience and WHO collaborating centres, and still partly under development. The contents list sections on the virus, transmission, clinical features, laboratory detection, case definitions and precautions for various health and non-health workers.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "care workers",
          "heading": false
        },
        {
          "term": "precautions",
          "heading": false
        },
        {
          "term": "service workers",
          "heading": false
        },
        {
          "term": "health care",
          "heading": false
        },
        {
          "term": "lav",
          "heading": false
        },
        {
          "term": "parenteral",
          "heading": false
        },
        {
          "term": "definitions",
          "heading": false
        },
        {
          "term": "contents",
          "heading": false
        }
      ],
      "extract": "GUIDELINES FOR THE PREVENTION AND CONTROL OF INFECTION WITH LAV/HTLV-IIY WHO has committed itself to the preparation and distribution of guidelines for the prevention and control of infection with LAV/HTLV-III. are broad in nature and therefore suitable for international application. They are based on the experience of many member countries and advice from the WHO AIDS and Biosafety Collaborating Centres. The",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-003"
      ]
    },
    {
      "id": "page-004",
      "number": null,
      "title": "Page 4",
      "level": 1,
      "pageStart": 4,
      "pageEnd": 4,
      "labelStart": null,
      "labelEnd": null,
      "words": 67,
      "summary": {
        "text": "Continues the contents of the 1986 LAV/HTLV-III guidelines, listing planned sections on guidance for health professionals, high-risk groups and the general population, and disinfection and sterilization.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "sterilization",
          "heading": false
        },
        {
          "term": "disinfectants",
          "heading": false
        },
        {
          "term": "lenses",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/AIDS/86.1 page 2 5. Guidance for health professionals 5.1* Screening 5.2* Diagnostic testing 5.3% Counselling of seropositive persone 6. Guidance for high risk groups and the general population 6.1* Prevention of sexual transmission 6,2* Pravention of parenteral transmission 6.3* Education and foster care 7, Disinfection and sterilization 1 Commonly available disinfectants -2 Sterilization .3 Processing",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-004"
      ]
    },
    {
      "id": "page-005",
      "number": null,
      "title": "Page 5",
      "level": 1,
      "pageStart": 5,
      "pageEnd": 5,
      "labelStart": null,
      "labelEnd": null,
      "words": 452,
      "summary": {
        "text": "Introduces the guidelines as part of the WHO AIDS Control Programme, aimed at public health authorities and health professionals who must adapt them to local settings, and notes they will be revised as knowledge grows. It describes the virus and states that only blood and semen have been implicated in transmission, through sexual, parenteral and perinatal routes.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "lav htlv-ii",
          "heading": false
        },
        {
          "term": "htlv-iii transmission",
          "heading": false
        },
        {
          "term": "acp",
          "heading": false
        },
        {
          "term": "body fluids",
          "heading": false
        },
        {
          "term": "epidemiological aspects",
          "heading": false
        },
        {
          "term": "retrovirus",
          "heading": false
        },
        {
          "term": "virus",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/ATDS/86.1 page 3 GUIDELINES FOR THE PREVENTION AND CONTROL OF INFECTION WITH LAV/HTLV-II1 1. Introduction -An important component of the WHO AIDS Control Programme (ACP) is preparation and distribution of guidelines, manuals and educational materials on prevention and control of LAV/HTLV-III infections for professional personnel, for groups at risk and for the general public. The ultimate goal of the ACP",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-005"
      ]
    },
    {
      "id": "page-006",
      "number": null,
      "title": "Page 6",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 6,
      "labelStart": null,
      "labelEnd": null,
      "words": 444,
      "summary": {
        "text": "Explains that sexual transmission is the most important route worldwide, alongside transmission through blood, blood products, shared needles and from mother to child, and that the virus is not spread by casual contact, insects, food or water. It begins describing clinical features and laboratory methods for detecting infection.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "chronic diarrhea",
          "heading": false
        },
        {
          "term": "htlv-iii infection",
          "heading": false
        },
        {
          "term": "clinical manifestations",
          "heading": false
        },
        {
          "term": "opportunistic infections",
          "heading": false
        },
        {
          "term": "weight loss",
          "heading": false
        },
        {
          "term": "factors viii",
          "heading": false
        },
        {
          "term": "semen",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/AIDS/86.1 page 4 Worldwide, the most important wode of transmission is sexual, LAV/RTLV-ILL can spread bi-directionally between heterosexual or homosexual partners, Transmission of LAV/ATLV-III through semen donation has also been documented, Parenteral LAV/HTLV-IIL transmission can occur through transfusion of whole blood, blood cells, platelets, or factors VIII or IX derived from contaminated human plasma,",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-006"
      ]
    },
    {
      "id": "page-007",
      "number": null,
      "title": "Page 7",
      "level": 1,
      "pageStart": 7,
      "pageEnd": 7,
      "labelStart": null,
      "labelEnd": null,
      "words": 504,
      "summary": {
        "text": "Describes antibody testing by ELISA, which is highly sensitive but gives some false positives, so repeatedly reactive samples should be confirmed with another test. It then introduces the WHO/CDC case definition of AIDS based on opportunistic diseases indicating cellular immunodeficiency.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "htlv-iii infections",
          "heading": false
        },
        {
          "term": "case definition",
          "heading": false
        },
        {
          "term": "false positives",
          "heading": false
        },
        {
          "term": "aids",
          "heading": false
        },
        {
          "term": "elisa",
          "heading": false
        },
        {
          "term": "cdc",
          "heading": false
        },
        {
          "term": "seropositive",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/AIDS/86.1 page 5 infection in the community, assessing the likelihood that an individual has been exposed to LAV/HILV-III, and evaluating various methods of preventing or treating the disease, At present, the only practical approach for routine or large-scale testing is detection of antibody to LAV/HTLV-III and the enzyme-linked immunosorbent assay (ELISA) is the antibody detection method most frequently",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-007"
      ]
    },
    {
      "id": "page-008",
      "number": null,
      "title": "Page 8",
      "level": 1,
      "pageStart": 8,
      "pageEnd": 8,
      "labelStart": null,
      "labelEnd": null,
      "words": 400,
      "summary": {
        "text": "Completes the WHO/CDC AIDS case definition, including exclusion criteria based on negative tests and normal T-helper counts. It then gives the clinical case definitions for adults and begins the definition for paediatric AIDS.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "cellular immunodeficiency",
          "heading": false
        },
        {
          "term": "minor signs",
          "heading": false
        },
        {
          "term": "known causes",
          "heading": false
        },
        {
          "term": "case definition",
          "heading": false
        },
        {
          "term": "major signs",
          "heading": false
        },
        {
          "term": "severe malnutrition",
          "heading": false
        },
        {
          "term": "lav",
          "heading": false
        },
        {
          "term": "leu",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/AIDS/86,1 page 6 - absence of all known underlying causes of cellular immunodeficiency Cother than LAV/HTLV-III infection) and absence of a11 other causes of reduced resistance reported to be associated with at least one of those opportunistic diseases. Despite having the above, patients are excluded as AIDS cases if they have negative result(s) on testing for serum antibody to LAV/HTLV-IIT, do not have a",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-008"
      ]
    },
    {
      "id": "page-009",
      "number": null,
      "title": "Page 9",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 9,
      "labelStart": null,
      "labelEnd": null,
      "words": 423,
      "summary": {
        "text": "Lists major and minor signs for the clinical definition of paediatric AIDS and calls for evaluating clinical definitions in different settings. It opens the recommendations for health care workers, stressing avoidance of exposure to patients' blood and keeping workers with weeping lesions from direct patient contact.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "prevent lav",
          "heading": false
        },
        {
          "term": "htlv-iii transmission",
          "heading": false
        },
        {
          "term": "infected patients",
          "heading": false
        },
        {
          "term": "hcws",
          "heading": false
        },
        {
          "term": "care workers",
          "heading": false
        },
        {
          "term": "clinical case",
          "heading": false
        },
        {
          "term": "precautions",
          "heading": false
        }
      ],
      "extract": "WHO/CDS /AIDS/86.1 page 7 Major signs bad weight loss or abnormally slow growth; - chronic diarrhoea > 1 month; - prolonged fever 5 1 month, Minor signs - generalized lymphadenopathy; - oro-pharyngeal candidiasis; ~ repeated common infections (otitis, pharyngitis, etc.) - persistent cough; - generalized dermatitis; - confirmed maternal LAV/HTLV-LII infection These clinical case definitions are believed to be",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-009"
      ]
    },
    {
      "id": "page-010",
      "number": null,
      "title": "Page 10",
      "level": 1,
      "pageStart": 10,
      "pageEnd": 10,
      "labelStart": null,
      "labelEnd": null,
      "words": 538,
      "summary": {
        "text": "Sets out precautions for health care workers against bloodborne infections, including careful handling and disposal of sharps without recapping, safe destruction of disposable needles and syringes, and use of gloves, gowns and masks where appropriate. It also covers handling of specimens, waste and reusable instruments, including those with lenses.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "disposable needles",
          "heading": false
        },
        {
          "term": "reusable needles",
          "heading": false
        },
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "blood precautions",
          "heading": false
        },
        {
          "term": "blood specimens",
          "heading": false
        },
        {
          "term": "accidental injuries",
          "heading": false
        },
        {
          "term": "body fluids",
          "heading": false
        },
        {
          "term": "infectious wastes",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/ATDS /86.1 page & requires tigorous sterilization of reusable equipment such as needles, syringes and skin~plercing instruments. 2.1 Precautions for HCWs These precautions represent prudent practices that apply to preventing transmission of all bloodborne infections and should be used routinely. 2.4.1. Sharp items (needles, scalpel blades, and other instruments) should be considered as potentially infective,",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-010"
      ]
    },
    {
      "id": "page-011",
      "number": null,
      "title": "Page 11",
      "level": 1,
      "pageStart": 11,
      "pageEnd": 11,
      "labelStart": null,
      "labelEnd": null,
      "words": 467,
      "summary": {
        "text": "Recommends disposable or safely sterilized needles and syringes, explains that single-room isolation is not usually needed except in specific circumstances, and advises on resuscitation equipment. It also covers precautions for home care and pre-hospital emergency care providers.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "htlv-iii infected",
          "heading": false
        },
        {
          "term": "pre-hospital emergency",
          "heading": false
        },
        {
          "term": "infected patients",
          "heading": false
        },
        {
          "term": "emergency care",
          "heading": false
        },
        {
          "term": "precautions outlined",
          "heading": false
        },
        {
          "term": "hcws",
          "heading": false
        },
        {
          "term": "home care",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/ATDS/86.1 page 9 2.1.6, Disposable needles and syringes are preferred. Only needle-locking syringes or one-piece needle-syringe units should be used to aspirate fluids from patients, so that collected fluid can be safely discharged through the needle, if desired, If reusable syringes are employed, they must be sterilized before reuse (see section 7.3) and special care must be taken in handling to avoid",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-011"
      ]
    },
    {
      "id": "page-012",
      "number": null,
      "title": "Page 12",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 12,
      "labelStart": null,
      "labelEnd": null,
      "words": 463,
      "summary": {
        "text": "Describes managing needlestick or mucous membrane exposures, including assessing the source patient and testing and following up exposed workers for up to a year. It then sets out laboratory precautions, such as using biological safety cabinets for procedures likely to create aerosols.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "mucous membrane",
          "heading": false
        },
        {
          "term": "membrane exposure",
          "heading": false
        },
        {
          "term": "body fluids",
          "heading": false
        },
        {
          "term": "htlv-iii infection",
          "heading": false
        },
        {
          "term": "hcw",
          "heading": false
        },
        {
          "term": "source patient",
          "heading": false
        },
        {
          "term": "containment",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/AIDS/86,1 page 10 blood or other body fluids should be used once and disposed or be thoroughly cleaned and disinfected (see section 7,1). 2.4 Management of parenteral and mucous membrane exposure lt a HCW has a parenteral (e.g,, needlestick or cut) or mucous membrane (e.g., splash to eye or mouth) exposure to blood or other body fluids, the source patient should be assessed clinically and epidemiologically",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-012"
      ]
    },
    {
      "id": "page-013",
      "number": null,
      "title": "Page 13",
      "level": 1,
      "pageStart": 13,
      "pageEnd": 13,
      "labelStart": null,
      "labelEnd": null,
      "words": 376,
      "summary": {
        "text": "Continues laboratory precautions, including shielding cell sorters, decontaminating surfaces and materials, hand washing and banning eating or smoking in the laboratory, and gives precautions for animal work. Sections on dental care, necropsies and morticians are marked as still in preparation.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "inoculated animals",
          "heading": false
        },
        {
          "term": "experimental animals",
          "heading": false
        },
        {
          "term": "aerosols",
          "heading": false
        },
        {
          "term": "droplets",
          "heading": false
        },
        {
          "term": "decontaminated",
          "heading": false
        },
        {
          "term": "cages",
          "heading": false
        },
        {
          "term": "excreta",
          "heading": false
        },
        {
          "term": "gloves",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/ATDS/86.1 page 11 eges. Fluorescent activated cell sorters generate droplets that could potentially result in infectious aerosols, Translucent plastic shielding between the droplet-collecting area and the equipment operator should be used to reduce the presently uncertain magnitude of this risk, Primary containment devices are also used in handling materials that might contain concentrated infectious agents",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-013"
      ]
    },
    {
      "id": "page-014",
      "number": null,
      "title": "Page 14",
      "level": 1,
      "pageStart": 14,
      "pageEnd": 14,
      "labelStart": null,
      "labelEnd": null,
      "words": 529,
      "summary": {
        "text": "Covers non-health care workers, advising that personal service workers who pierce the skin follow health worker precautions and properly disinfect instruments, though no transmission has been documented in such settings. It states that food service workers with LAV/HTLV-III need not be restricted from work unless they have other illnesses.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "food service",
          "heading": false
        },
        {
          "term": "ear piercing",
          "heading": false
        },
        {
          "term": "personal service",
          "heading": false
        },
        {
          "term": "service workers",
          "heading": false
        },
        {
          "term": "whose occupations",
          "heading": false
        },
        {
          "term": "penetrate",
          "heading": false
        },
        {
          "term": "workers known",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/AIDS/86,1 page 12 2.9 Eye examiners* 3. Considerations relevant to non health cate workers 3.1 Personal service workers Personal service workers are defined as individuals whose occupations involve close personal contact with clients (e.g. hairdressers, barbers, manicurists, pedicurists, massage therapists). Personal service workers whose services (tattoolng, ear piercing, acupuncture, etc.) require needles",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-014"
      ]
    },
    {
      "id": "page-015",
      "number": null,
      "title": "Page 15",
      "level": 1,
      "pageStart": 15,
      "pageEnd": 15,
      "labelStart": null,
      "labelEnd": null,
      "words": 364,
      "summary": {
        "text": "States that infected workers in offices, schools and other settings pose no known risk and should not be restricted, with routine cleaning of contaminated equipment. It notes some sections are pending and begins the section on disinfection, describing sodium hypochlorite and differences in strength of household bleach products between countries.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "lav htlv-iii",
          "heading": false
        },
        {
          "term": "sodium hypochlorite",
          "heading": false
        },
        {
          "term": "household bleach",
          "heading": false
        },
        {
          "term": "stock solutions",
          "heading": false
        },
        {
          "term": "disinfectants",
          "heading": false
        },
        {
          "term": "water",
          "heading": false
        },
        {
          "term": "disinfection",
          "heading": false
        },
        {
          "term": "care facilities",
          "heading": false
        }
      ],
      "extract": "wHo/cps/AIDS/86.1 page 13 3,3 Workers sharing same work environment No known risk of transmission to coworkers, clients of consumers exists from LAV/HTLV-III infected workers in other settings (e.g. offices, schools, factories, construction sites), Workers known to be infected with LAV/HTLV-III should not be restricted from work solely based on this finding. Moreover, they should not be restricted from using",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-015"
      ]
    },
    {
      "id": "page-016",
      "number": null,
      "title": "Page 16",
      "level": 1,
      "pageStart": 16,
      "pageEnd": 16,
      "labelStart": null,
      "labelEnd": null,
      "words": 385,
      "summary": {
        "text": "Gives contact times for disinfectants such as formalin, ethanol and glutaraldehyde, and describes sterilization by autoclaving or boiling and high-level disinfection of heat-sensitive equipment. It sets out a step-by-step method for processing reusable needles and syringes.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "reusable syringes",
          "heading": false
        },
        {
          "term": "disinfectant solution",
          "heading": false
        },
        {
          "term": "minute contact",
          "heading": false
        },
        {
          "term": "contact time",
          "heading": false
        },
        {
          "term": "needle",
          "heading": false
        },
        {
          "term": "sterilization",
          "heading": false
        },
        {
          "term": "disinfection",
          "heading": false
        },
        {
          "term": "litre",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/AIDS/86.1 page 14 4 10 to 30 minute contact time is required depending upon level of contamination of material to be disinfected. 7.1.2, Formaldehyde as Formalin: 50 g/litre (5%). 10-30 minute contact time. 7.143, Ethanol; 700 g/litre (702). 10-30 minute contact time, 7.1.4, Glutaraldehyde: 20 g/litve (24). 10-30 minute contact time. 7.2 Sterilization 7.2.1 Ideally, all reusable patient care equipment and",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-016"
      ]
    },
    {
      "id": "page-017",
      "number": null,
      "title": "Page 17",
      "level": 1,
      "pageStart": 17,
      "pageEnd": 17,
      "labelStart": null,
      "labelEnd": null,
      "words": 28,
      "summary": {
        "text": "Ends the processing steps with sterilizing needles and syringes before reuse, and lists the care of eye instruments and contact lenses as a section still in preparation.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "WHO/CDS/AIDS/86.1 page 15 ~ Disinfect or sterilize syringe and needle by autoclaving (steam sterilizer) or boiling prior to reuse, 7.4 Care of eye examination instruments and contact lenses*",
      "extractCut": false,
      "blocks": [
        "library/10665-59577/blocks/prose-page-017"
      ]
    },
    {
      "id": "page-018",
      "number": null,
      "title": "Page 18",
      "level": 1,
      "pageStart": 18,
      "pageEnd": 18,
      "labelStart": null,
      "labelEnd": null,
      "words": 5,
      "summary": {
        "text": "A blank page with no extracted text.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "_(no text on this page)_",
      "extractCut": false,
      "blocks": [
        "library/10665-59577/blocks/prose-page-018"
      ]
    },
    {
      "id": "page-019",
      "number": null,
      "title": "Page 19",
      "level": 1,
      "pageStart": 19,
      "pageEnd": 19,
      "labelStart": null,
      "labelEnd": null,
      "words": 279,
      "summary": {
        "text": "Presents the first page of WHO's provisional 1986 AIDS reporting form, asking countries to report cases meeting the WHO/CDC or clinical definitions and how many clinical cases were serotested and confirmed. It also asks for cases by age, sex and disease category, such as opportunistic infection or Kaposi's sarcoma, with footnotes on reporting periods and totals.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "kaposi sarcoma",
          "heading": false
        },
        {
          "term": "equal number",
          "heading": false
        },
        {
          "term": "total number",
          "heading": false
        },
        {
          "term": "cases reported",
          "heading": false
        },
        {
          "term": "clinical cases",
          "heading": false
        },
        {
          "term": "cases meeting",
          "heading": false
        },
        {
          "term": "opportunistic infection",
          "heading": false
        },
        {
          "term": "case definition",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/ATDS/86.1 Annex 1 page 1 Provisional WORLD HEALTH ORGANIZATION 2 April 1986 REPORTING FORM ON ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) Reporting Officer: Name (code) of country: Unit/department: Reporting period 1: 1. Date of report: Monthi: Quarter!,: LA. Number of cases meeting CDC/WHO case definition” 1B. Number of cases meeting clinical case definition? but not CDC/WHO case definition Of clinical cases,",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-019"
      ]
    },
    {
      "id": "page-020",
      "number": null,
      "title": "Page 20",
      "level": 1,
      "pageStart": 20,
      "pageEnd": 20,
      "labelStart": null,
      "labelEnd": null,
      "words": 319,
      "summary": {
        "text": "Continues the AIDS reporting form, asking for adult and paediatric cases by risk factor and sex and for numbers of resident, imported and visiting cases. Footnotes explain the hierarchical risk categories and how totals should match.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "homosexual male",
          "heading": false
        },
        {
          "term": "factor male",
          "heading": false
        },
        {
          "term": "blood transfusion",
          "heading": false
        },
        {
          "term": "male female",
          "heading": false
        },
        {
          "term": "heterosexual contact",
          "heading": false
        },
        {
          "term": "female unknown",
          "heading": false
        },
        {
          "term": "paediatric cases",
          "heading": false
        },
        {
          "term": "unknown total",
          "heading": false
        }
      ],
      "extract": "WHO/CDS/AIDS/86.1 Annex 1 page 2 5. Risk factor 5A. 1 Adult cases (15 years old or older) Risk factor Male Female |Unknown | Total Homosexual male Bisexual male Intravenous drug user Haemophiliac Heterosexual contact? Blood transfusion? Other No risk factor? Unknown® Total number of adult cases 5B. Paediatric cases ( “¢ 15 years old) Risk factor Male Female {Unknown | Total Parent with LAV/HTLV-III antibody/ARC/AIDS",
      "extractCut": true,
      "blocks": [
        "library/10665-59577/blocks/prose-page-020"
      ]
    }
  ],
  "checks": {},
  "withheld": false,
  "keywords": [
    {
      "term": "lav htlv-iii",
      "heading": false
    },
    {
      "term": "lav hilv-iii",
      "heading": false
    },
    {
      "term": "lav htlv-i1i",
      "heading": false
    },
    {
      "term": "lav htlv-iil",
      "heading": false
    },
    {
      "term": "lav htlv-iit",
      "heading": false
    },
    {
      "term": "prevent lav",
      "heading": false
    },
    {
      "term": "lav htlv",
      "heading": false
    },
    {
      "term": "lav htlv-ii",
      "heading": false
    },
    {
      "term": "lav htlv-i",
      "heading": false
    },
    {
      "term": "htlv-iii infected",
      "heading": false
    },
    {
      "term": "htlv-iii infection",
      "heading": false
    },
    {
      "term": "htlv-iii transmission",
      "heading": false
    }
  ],
  "coverage": [
    {
      "kind": "contents",
      "state": "not-extracted",
      "note": "split one section per page; no contents was trusted"
    },
    {
      "kind": "sections",
      "state": "partial",
      "count": 20,
      "note": "one per page, not by heading"
    },
    {
      "kind": "figures",
      "state": "none"
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "found",
      "count": 20,
      "note": "20 of 20 sections"
    }
  ],
  "links": {
    "repo": "litlfred/who-iris",
    "branch": "main",
    "dir": "library/10665-59577"
  }
}
